Boston Scientific's $3.7B Axonics buy tops list of medtech M&A in 2024

Photo of Michael F. Mahoney, CEO of Boston Scientific. In January, Boston Scientific said it would buy Axonics for $3.7 billion. Courtesy of Boston …

Do you trust this headline?

Based on recent headline ratings, 91% of this readership currently trusts the local media, which has an average score of 73% regionally and is currently trending positive.


Media Trust Score91%